Dual bronchodilators better than inhaled steroids for COPD

Dual bronchodilators may be a more effective way of preventing COPD exacerbations than using an inhaled steroid-bronchodilator combination, research suggests.

Treatment with an inhaled long-acting beta-agonist (LABA) combined with a long-acting muscarinic antagonist (LAMA) is more effective at preventing exacerbations than a combination of LABA and inhaled corticosteroid, according to a randomised controlled trial in patients with moderate to severe COPD.

And the findings suggest that current COPD-X guidelines — which recommend an inhaled